Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT02825160 · COMPLETED

Trial details

NCT number: NCT02825160
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Hypertension, Pulmonary

Start date: 2016-08-01
Primary completion: 2023-03-31
Enrollment: 282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.